Abstract
The mutation R403stop was found in an individual with mut0 methylmalonic aciduria (MMA) which resulted from a single base change of C→T in exon 6 of the methylmalonyl-CoA mutase gene (producing a TGA stop codon). In order to accurately model the human MMA disorder we introduced this mutation onto the human methylmalonyl-CoA mutase locus of a bacterial artificial chromosome. A mouse model was developed using this construct.The transgene was found to be intact in the mouse model, with 7 copies integrated at a single site in chromosome 3. The phenotype of the hemizygous mouse was unchanged until crossed against a methylmalonyl-CoA mutase knockout mouse. Pups with no endogenous mouse methylmalonyl-CoA mutase and one copy of the transgene became ill and died within 24 hours. This severe phenotype could be partially rescued by the addition of a transgene carrying two copies of the normal human methylmalonyl-CoA mutase locus. The “humanized” mice were smaller than control litter mates and had high levels of methylmalonic acid in their blood and tissues.This new transgenic MMA stop codon model mimics (at both the phenotypic and genotypic levels) the key features of the human MMA disorder. It will allow the trialing of pharmacological and, cell and gene therapies for the treatment of MMA and other human metabolic disorders caused by stop codon mutations.
Highlights
Disruption of the conversion of methylmalonyl-CoA to succinylCoA results in an increased level of metabolites in tissues and fluids of the body
Recombination The R403stop mutation was inserted into the human mutase locus of bacterial artificial chromosome (BAC), RPCI-11-463L20 by a two-stage homologous recombination
The mouse model contains the human methylmalonyl-CoA mutase locus carrying a stop codon mutation identified from a patient with mut0 methylmalonic aciduria (MMA)
Summary
Disruption of the conversion of methylmalonyl-CoA to succinylCoA results in an increased level of metabolites in tissues and fluids of the body. This inherited disorder, methylmalonic aciduria (MMA), can be caused by stop mutations in the methylmalonylCoA mutase gene (MUT). Molecular studies of our population of mutase deficient MMA individuals identified 4 out of 7 individuals were compound heterozygous for mutations which added a stop codon, the full length enzyme subunits of methylmalonyl-CoA mutase were not produced and the enzyme was inactive (4, plus unpublished data). One way to treat these disorders is to reduce the efficiency of translation termination at stop codons and produce some full length protein
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.